Knowlesi18 Dec 2018 20:57
Almost forgot to mention, when you say...........""".I do think a lot of people have completely lost faith and hence sold up "" I think we forget many of those will gladly come back even if they have to pay significantly more, on good news and a rising SP.
I was listening to the AGM tape last week, and i felt the BOD were being very careful in their wordings as to future progress What i was trying to get too before was if we have fallen primarily because of delays to SCIB 1 and a seeming lack of good news, just perhaps meeting our deadline and another item of good news will cause a rerate next year, and see a migration back to a Scancell taking off.
I was giving the BOD a hard time last year over what i saw as a lack of communication in keeping interest going with shareholders, I think some of my criticism over news flow was a bit unfair, what were Scancell meant to do, warn ustrial would be delayed because of Tri Grid 2 and see us open 20" down? or just let us see how it plays out. A tricky one, i just feel they know now as CH mailed me twice, "we are very hopeful our relationship with BioNTech will bear more fruit". The additions of ISA, Oncimmune, BioNTech and the GC team somehowshow me the enormous changes to our structure and end product, including Amplivant. Wouldn"t we all like the opportunity of being locked in with the BOD and asking three questions.
We just don"t know what could come next, but to ignore what has improved in clinical development is foolish. We have something many want many need and we have Lindy Durrant, i"m in her team. ATB
Sign In
Follow the stocks
